Zdravotnictví

Genome Therapeutics Adds New President and Chief Operating Officer / Appoints Dr. Richard D. Gill, Former General Manager of BTG plc's North American Operations

16.12.1999 14:08

WALTHAM, Mass. (PROTEXT) - Genome Therapeutics Corp. (Nasdaq:GENE), a leader in the field of genomics, today announced theappointment of Richard D. Gill, Ph.D., as President and ChiefOperating Officer, effective January 3, 2000. Dr. Gill succeedsRobert...

Zadavatel:

Bristol-Myers Squibb and OXiGENE Announce Research and Licensing Agreement For Combretastatin Anti-Tumor Agents / Novel Compounds Target Blood Vessels Necessary

16.12.1999 13:00

PRINCETON, N.J., BOSTON, and STOCKHOLM, Sweden (PROTEXT) -Bristol-Myers Squibb Company (NYSE: BMY) and OXiGENE, Inc.(Nasdaq: OXGN; Sweden) today announced an exclusive licensingagreement and research collaboration to develop and commercializecombretastatin...

Zadavatel:

Switzerland Is the First Country to Give Market Approval for Visudyne Therapy for AMD

16.12.1999 12:58

ATLANTA and VANCOUVER, British Columbia (PROTEXT) - CIBAVision, the eye care unit of Novartis, and QLT PhotoTherapeuticsInc. (Nasdaq: QLTI; Toronto) announced today that the SwissRegulatory Agency -- Interkantonale Kontrollstelle für Heilmittel-- has...

Zadavatel:

Hemispherx Announces New Approach to HIV-Inhibition / Test Results Show Potential Advantages of Ampligen(R) as Anti-HIV Agent

15.12.1999 09:30

Philadelphia (PROTEXT) - Hemispherx Biopharma, Inc. (Amex:HEB; HEBws) today announced that recent independent laboratorytest results show potential advantages of its product Ampligen(R)as an anti-HIV agent. According to findings presented today at the...

Zadavatel:

Společnost Bioheart, Inc. [a.s.] se bude prezentovat na konferenci o kardiovaskulární genomice, která se bude konat ve dnech 31. ledna a 1. února 2000 v Miami n

13.12.1999 16:21

Weston, Florida (PROTEXT) - Bioheart, Inc.(www.bioheartinc.com), společnost, která se zaměřuje naprevenci a léčbu infarktu myokardu, se bude prezentovat nakonferenci v Miami, pořádané ve dnech 31. ledna a 1. února 2000. Společnost se specializuje na...

Zadavatel:

Rada pro prevenci epidemické hepatitidy (VIRAL HEPATITIS PREVENTION BOARD, VHPB) doporučuje evropským obcím s opakovaným výskytem epidemií, aby zvážily univerzá

13.12.1999 00:01

ANTVERPY 13. prosince (PROTEXT/PRNewswire) - Rada proprevenci epidemické hepatitidy (Viral Hepatitis Prevention Board,VHPB), nezávislá poradenská skupina pro epidemickou hepatitidu,doporučuje, aby evropské obce, v nichž je výskyt hepatitidy Apodstatně...

Zadavatel:

Safety and Efficacy of Herceptin + Chemotherapy Further Supported by Studies Presented at Breast Cancer Conference

10.12.1999 10:15

SAN ANTONIO (PROTEXT) - New advances in the study ofHerceptin(R) (trastuzumab), when used in combination with commonchemotherapies for the treatment of advanced (metastatic) breastcancer, were highlighted in two presentations at the 22nd AnnualSan Antonio...

Zadavatel:

ICN's Motion for Summary Judgment Continued for Six Months / Company Notes Insider Trading Allegations Against Chairman Were Never Claimed David Watt, ICN Offic

10.12.1999 10:14

COSTA MESA, Calif. (PROTEXT) - ICN Pharmaceuticals, Inc.(NYSE: ICN) and Milan Panic announced today that they wouldproceed expeditiously to conduct discovery in response to aDecember 8, 1999, court order continuing for six months theirmotion for summary...

Zadavatel:

Zila to Market Swab Version of OraTest Product / Scheduled to Join Rinse Version in China in January 2000

9.12.1999 17:30

London (PROTEXT) - Zila Europe, a division of Zila, Inc.(Nasdaq: ZILA), international provider of healthcare products fordental/medical professionals and consumers, announced that itwill introduce new OraTest(R) Swab, a variation of Zila'sOraTest(R)...

Zadavatel:

GE Marquette Medical Systems and Critikon Sign Agreement to Form Global Alliance / Companies Join to Support a $2.2 Billion Global Patient Monitoring Market

9.12.1999 09:01

Tampa, Fla. and Milwaukee (PROTEXT) - Critikon Company LLC andGE Marquette Medical Systems (NYSE: GE) announced today that thecompanies have agreed to form a global alliance to jointlydevelop and distribute patient monitoring equipment and suppliesused...

Zadavatel:

HIV, Flu & HBV/HCV Focus of Antiviral Drug Discovery Conference on March 15-16, 2000, in New Jersey

8.12.1999 16:15

Princeton, New Jersey (PROTEXT) - Pharmaceutical industryadvances in the discovery and development of novel antiviralagents in HIV, influenza/respiratory, and hepatitis B & C, willbe presented in depth on March 15-16, 2000 at the Hyatt RegencyHotel...

Zadavatel:

Global Enhancing Care Initiative Develops Comprehensive Framework To Improve HIV/AIDS Care in Resource-Poor Countries

8.12.1999 09:57

Paris (PROTEXT) - Local Experts Join Together to Improve theLevels of Care and Provide Long-Term, Sustainable Solutions. A new nine-point AIDS care framework which outlines acomprehensive approach to enhance HIV/AIDS care within resource-poor regions...

Zadavatel:

Global Enhancing Care Initiative Develops Comprehensive Framework To Improve HIV/AIDS Care in Resource-Poor Countries

7.12.1999 21:49

Paris (PROTEXT) - Local Experts Join Together to Improve theLevels of Care and Provide Long-Term, Sustainable Solutions. A new nine-point AIDS care framework which outlines acomprehensive approach to enhance HIV/AIDS care within resource-poor regions...

Zadavatel:

Bill a Melinda Gatesovi a Ted Turner přispějí 78 milióny dolarů na urychlení kampaně k vymýcení obrny do konce roku 2000

7.12.1999 18:19

ŽENEVA 7. prosince (PROTEXT/ots-PRNewswire) - Finanční darypomohou podpořit kampaň Světové zdravotnické organizace (WHO),společnosti Rotary International a Dětského fondu OSN (UNICEF),jejímž cílem je získat 400 miliónů dolarů na definitivníodstranění...

Zadavatel:

Nelson Mandela, Bill Gates to Address Global Health Challenges

7.12.1999 07:17

Seattle, Washington (ots-PRNewswire) - Leaders Expected toUrge Businesses, Governments and Philanthropists to Help ImproveAccess to Medical Advances for Developing Nations 1999 Former South African President Nelson Mandela will join BillGates, co-founder...

Zadavatel:

Domain Pharma Corporation a Integrated Clinical Systems, Inc. ohlásily na prosinec 1999 přístupnost webové verze Integrated Review

2.12.1999 10:16

LEXINGTON (Mass.) 2. prosince (PROTEXT/ots) - JReview(TM)rozšiřuje přístup ke klinickým datům prostřednictvím Webu. Domain Pharma Corporation, přední světový poskytovatelsoftwaru pro řízení klinických zkoušek a regulačních dat, aIntegrated Clinical Systems,...

Zadavatel:

Abbott Laboratories Receives European Commission Marketing Authorization For Reformulated Norvir(R) (Ritonavir) Capsules

1.12.1999 14:57

ABBOTT PARK, Ill. (PROTEXT) - Abbott Laboratories announcedtoday it has received marketing authorization from the EuropeanCommission for Norvir(R) (ritonavir) soft capsules. Norvir is aprotease inhibitor indicated in combination with otherantiretroviral...

Zadavatel:

Hemispherx Biopharma Enters Agreement with Schering Plough

1.12.1999 11:07

PHILADELPHIA (PROTEXT) - Hemispherx Biopharma, Inc. (Amex:HEB) today announced that it has entered into a multi-year drug-production agreement with Schering-Plough Products L.L.C.,regarding Hemispherx's antiviral product, Ampligen(R). The Ampligen(R)...

Zadavatel:

LifeStream International Announces Letter Of Intent to Acquire Polystan AS of Denmark

30.11.1999 15:39

Haverhill, Mass. (PROTEXT) - LifeStream International, Inc., aleading global cardiopulmonary products company, today announcedit has signed a letter of intent to acquire Polystan AS, amanufacturer and marketer of a wide range of cardiopulmonaryproducts...

Zadavatel:

Konsorcium SNP dalo poprvé k dispozici první sadu genetických znaků/ Víc než 2000 nových polyformismů (SNP) je nyní přístupno zdravotnickým výzkumníkům na celém

24.11.1999 14:27

CHICAGO (USA) 24. listopadu (PROTEXT/ots) - Mapa SNP mápomoci objevit a vyvíjet bezpečnější a účinnější léčebné postupy. Konsorcium SNP Ltd., které je společenství usilující ovytvoření databáze genetických znaků zvaných jednoduchénukleotické polymorfismy...

Zadavatel:


Chci zadat tiskovou zprávu

Chci dostávat tiskové zprávy

Vaše tiskové zprávy rozšíříme spolu se zpravodajstvím ČTK uživatelům agenturního servisu jako jsou média, ekonomická sféra, státní správa a veřejnost. Texty zůstávají uloženy v Infobance ČTK, jsou součástí mobilní aplikace ČTK a obdrží je také tisíce odběratelů našeho e-mail servisu. Veřejnosti je zpřístupníme na více než 15 zpravodajských portálech.

Doporučujeme

Slavnostní vyhlášení prestižní soutěže Czech Press Photo 2026

Protext služby